Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs GLENMARK PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES GLENMARK PHARMA ALKEM LABORATORIES/
GLENMARK PHARMA
 
P/E (TTM) x 29.4 12.6 234.1% View Chart
P/BV x 4.5 1.2 364.4% View Chart
Dividend Yield % 1.0 0.6 166.1%  

Financials

 ALKEM LABORATORIES   GLENMARK PHARMA
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-22
GLENMARK PHARMA
Mar-22
ALKEM LABORATORIES/
GLENMARK PHARMA
5-Yr Chart
Click to enlarge
High Rs4,068691 589.0%   
Low Rs2,671416 642.7%   
Sales per share (Unadj.) Rs889.4436.1 203.9%  
Earnings per share (Unadj.) Rs140.535.2 399.1%  
Cash flow per share (Unadj.) Rs166.052.5 316.3%  
Dividends per share (Unadj.) Rs34.002.50 1,360.0%  
Avg Dividend yield %1.00.5 223.2%  
Book value per share (Unadj.) Rs722.4321.4 224.7%  
Shares outstanding (eoy) m119.57282.17 42.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.81.3 298.7%   
Avg P/E ratio x24.015.7 152.6%  
P/CF ratio (eoy) x20.310.5 192.6%  
Price / Book Value ratio x4.71.7 271.1%  
Dividend payout %24.27.1 340.8%   
Avg Mkt Cap Rs m402,868156,067 258.1%   
No. of employees `000NANA-   
Total wages/salary Rs m19,62724,474 80.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m106,342123,049 86.4%  
Other income Rs m1,6271,667 97.6%   
Total revenues Rs m107,968124,716 86.6%   
Gross profit Rs m20,38020,594 99.0%  
Depreciation Rs m3,0404,867 62.5%   
Interest Rs m5242,981 17.6%   
Profit before tax Rs m18,44314,412 128.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,6404,476 36.6%   
Profit after tax Rs m16,8039,936 169.1%  
Gross profit margin %19.216.7 114.5%  
Effective tax rate %8.931.1 28.6%   
Net profit margin %15.88.1 195.7%  
BALANCE SHEET DATA
Current assets Rs m84,35482,823 101.8%   
Current liabilities Rs m48,05346,894 102.5%   
Net working cap to sales %34.129.2 116.9%  
Current ratio x1.81.8 99.4%  
Inventory Days Days426 649.8%  
Debtors Days Days6592 70.3%  
Net fixed assets Rs m43,24571,148 60.8%   
Share capital Rs m239282 84.7%   
"Free" reserves Rs m86,13490,421 95.3%   
Net worth Rs m86,37390,703 95.2%   
Long term debt Rs m9425,717 0.4%   
Total assets Rs m127,599153,972 82.9%  
Interest coverage x36.25.8 620.7%   
Debt to equity ratio x00.3 0.4%  
Sales to assets ratio x0.80.8 104.3%   
Return on assets %13.68.4 161.9%  
Return on equity %19.511.0 177.6%  
Return on capital %21.914.9 146.8%  
Exports to sales %18.70-   
Imports to sales %00-   
Exports (fob) Rs m19,924NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m19,92432,142 62.0%   
Fx outflow Rs m3,91113,482 29.0%   
Net fx Rs m16,01318,660 85.8%   
CASH FLOW
From Operations Rs m11,11011,087 100.2%  
From Investments Rs m-14,351-3,333 430.6%  
From Financial Activity Rs m3,796-5,205 -72.9%  
Net Cashflow Rs m5802,724 21.3%  

Share Holding

Indian Promoters % 57.1 46.7 122.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 19.8 34.7 56.9%  
FIIs % 5.7 24.2 23.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 42.9 53.4 80.3%  
Shareholders   84,104 312,473 26.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   SUN PHARMA    DR. REDDYS LAB    CIPLA    LUPIN    PIRAMAL ENTERPRISES    


More on ALKEM LABORATORIES vs Glenmark Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ALKEM LABORATORIES vs Glenmark Pharma Share Price Performance

Period ALKEM LABORATORIES Glenmark Pharma S&P BSE HEALTHCARE
1-Day -0.66% -0.88% 0.17%
1-Month 7.49% 6.46% 3.70%
1-Year -16.66% -20.74% -9.00%
3-Year CAGR 19.19% 11.83% 25.64%
5-Year CAGR 12.21% -8.18% 11.19%

* Compound Annual Growth Rate

Here are more details on the ALKEM LABORATORIES share price and the Glenmark Pharma share price.

Moving on to shareholding structures...

The promoters of ALKEM LABORATORIES hold a 57.1% stake in the company. In case of Glenmark Pharma the stake stands at 46.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ALKEM LABORATORIES and the shareholding pattern of Glenmark Pharma.

Finally, a word on dividends...

In the most recent financial year, ALKEM LABORATORIES paid a dividend of Rs 34.0 per share. This amounted to a Dividend Payout ratio of 24.2%.

Glenmark Pharma paid Rs 2.5, and its dividend payout ratio stood at 7.1%.

You may visit here to review the dividend history of ALKEM LABORATORIES, and the dividend history of Glenmark Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Erases Gains to End Marginally Higher, Nifty Above 17,300; IT & Metal Stocks Witness Buying(Closing)

After opening the day on a strong note, Indian share markets pared gains as the session progressed and ended marginally higher.